296 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Download search resultsDownload the search results for:
Exclude Unknown | Expanded Access Studies (296 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Temporarily not available Autologous Platelet-rich Plasma (aPRP) for Complex Aortic Arch Surgerymacrovascular Operation
Condition: Autologous Blood Transfusion
Intervention: Procedure: Sorin XTRA/Sorin Group,
2 Available Compassionate Use of Aldoxorubicin in Sarcoma PatientsChemotherapy
Condition: Sarcoma
Intervention: Drug: aldoxorubicin
3 Available An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Panobinostat
4 Available Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
Condition: Refractory Gastroesophageal Reflux Disease With Upper Gastrointestinal (GI) Symptoms, Gastroparesis, and Chronic Constipation
Intervention: Drug: Domperidone
5 Available Cannabidiol for Pediatric Epilepsy (Compassionate Use)
Condition: Refractory Childhood Epilepsy
Intervention: Drug: cannabidiol (CBD)
6 Available Rociletinib (CO-1686) USA Expanded Access Program
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Rociletinib
7 No longer available Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Elotuzumab
8 Available Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Conditions: Hyperinsulinemic Hypoglycemia, Persistent;   Congenital Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
9 Available EAP of CPX-351 for Patients 60-75 Years of Age With Secondary AML
Condition: Secondary AML
Intervention: Drug: CPX-351
10 Available Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Conditions: Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: 11C-choline;   Device: PET/CT Scan
11 Temporarily not available Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.
Condition: Sciatic Nerve Injury
Intervention: Biological: Autologous human Schwann cells
12 Available Triheptanoin (UX007) to Treat Citrate Transporter Deficiency
Conditions: Citrate Transporter Deficiency;   SLC13A5 Gene Mutation
Intervention: Drug: triheptanoin
13 Available Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Biological: asfotase alfa
14 Available Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy
Condition: Oncology Patients With Gastroparesis
Intervention: Drug: Oral Domperidone
15 No longer available Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair
Condition: Sciatic Nerve Injury
Intervention: Biological: Autologous Human Schwann cells
16 Available Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Daratumumab
17 Available Expanded Access Program With Nivolumab Monotherapy for Treatment of Advanced/Metastatic SqNSCLC After One Prior Systemic Regimen
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Nivolumab
18 Temporarily not available Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access
Conditions: Peripheral Arterial Disease;   Peripheral Vascular Diseases;   Critical Limb Ischemia
Intervention: Device: Bone marrow concentration device
19 Available Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Condition: Metastatic Cancer
Intervention: Biological: HER-2/neu Pulsed DC1 vaccine
20 Temporarily not available Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients
Condition: Neoplasm
Intervention: Drug: Crizotinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years